Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0644 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase | 0.0644 | 1 | 1 |
Entamoeba histolytica | aldose reductase, putative | 0.0644 | 1 | 1 |
Echinococcus granulosus | aldehyde reductase | 0.0458 | 0.5922 | 0.5922 |
Loa Loa (eye worm) | oxidoreductase | 0.0644 | 1 | 1 |
Trichomonas vaginalis | dihydrodiol dehydrogenase, putative | 0.0644 | 1 | 1 |
Brugia malayi | oxidoreductase, aldo/keto reductase family protein | 0.0644 | 1 | 1 |
Trypanosoma brucei | prostaglandin f synthase | 0.0644 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0644 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0644 | 1 | 1 |
Trypanosoma cruzi | aldo/keto reductase, putative | 0.0644 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0644 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0644 | 1 | 1 |
Onchocerca volvulus | 0.0644 | 1 | 1 | |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0644 | 1 | 1 |
Entamoeba histolytica | aldose reductase, putative | 0.0644 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0644 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0644 | 1 | 1 |
Plasmodium vivax | aldehyde reductase, putative | 0.0187 | 0 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0644 | 1 | 1 |
Leishmania major | aldehyde reductase, putative,oxidoreductase, putative | 0.0644 | 1 | 1 |
Brugia malayi | oxidoreductase, aldo/keto reductase family protein | 0.0644 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0644 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0644 | 1 | 1 |
Onchocerca volvulus | 0.0644 | 1 | 1 | |
Plasmodium vivax | oxidoreductase, aldo/keto reductase domain containing protein | 0.0187 | 0 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0644 | 1 | 1 |
Schistosoma mansoni | aldo-keto reductase | 0.0644 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0644 | 1 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0644 | 1 | 1 |
Giardia lamblia | Aldose reductase | 0.0644 | 1 | 0.5 |
Echinococcus multilocularis | aldehyde reductase | 0.0458 | 0.5922 | 0.5922 |
Leishmania major | prostaglandin f synthase, putative | 0.0644 | 1 | 1 |
Onchocerca volvulus | 0.0644 | 1 | 1 | |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0644 | 1 | 1 |
Trichomonas vaginalis | aldo/keto reductase, putative | 0.0644 | 1 | 1 |
Leishmania major | prostaglandin f2-alpha synthase/D-arabinose dehydrogenase | 0.0644 | 1 | 1 |
Brugia malayi | oxidoreductase, aldo/keto reductase family protein | 0.0644 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0644 | 1 | 1 |
Leishmania major | aldo-keto reductase-like protein | 0.0644 | 1 | 1 |
Onchocerca volvulus | 0.0644 | 1 | 1 | |
Echinococcus multilocularis | aldo keto reductase | 0.0644 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0644 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase | 0.0644 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0644 | 1 | 1 |
Trichomonas vaginalis | dihydrodiol dehydrogenase, putative | 0.0644 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0644 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0644 | 1 | 1 |
Mycobacterium leprae | PROBABLE OXIDOREDUCTASE | 0.0644 | 1 | 1 |
Onchocerca volvulus | 0.0644 | 1 | 1 | |
Toxoplasma gondii | aldose reductase, putative | 0.0644 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0644 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0644 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0644 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase | 0.0644 | 1 | 1 |
Trypanosoma cruzi | aldo-keto reductase | 0.0644 | 1 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0644 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0644 | 1 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0644 | 1 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0644 | 1 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0644 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0644 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0644 | 1 | 1 |
Trichomonas vaginalis | aldo/keto reductase, putative | 0.0644 | 1 | 1 |
Schistosoma mansoni | pol-related | 0.0644 | 1 | 1 |
Trypanosoma brucei | aldo-keto reductase, putative | 0.0644 | 1 | 1 |
Echinococcus granulosus | hypothetical protein | 0.0644 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0644 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0644 | 1 | 1 |
Plasmodium falciparum | aldo-keto reductase, putative | 0.0187 | 0 | 0.5 |
Giardia lamblia | Aldose reductase | 0.0644 | 1 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0644 | 1 | 1 |
Trichomonas vaginalis | aldo/keto reductase, putative | 0.0644 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase | 0.0644 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase | 0.0644 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0644 | 1 | 1 |
Mycobacterium ulcerans | oxidoreductase | 0.0644 | 1 | 1 |
Schistosoma mansoni | aldo-keto reductase | 0.0644 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase | 0.0644 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0644 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0644 | 1 | 1 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0458 | 0.5922 | 0.5922 |
Trichomonas vaginalis | dihydrodiol dehydrogenase, putative | 0.0644 | 1 | 1 |
Onchocerca volvulus | 0.0644 | 1 | 1 | |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0644 | 1 | 1 |
Entamoeba histolytica | aldose reductase, putative | 0.0644 | 1 | 1 |
Plasmodium falciparum | aldehyde reductase, putative | 0.0187 | 0 | 0.5 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0644 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = -1.91 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 0 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 2 % | GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 4.84 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 5.1 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 10 % | GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM. | ChEMBL. | 20485427 |
Inhibition (functional) | = 94 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition frequency index (IFI) (functional) | = 2.99 | Inhibition Frequency Index (IFI) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 0 % | Percent inhibition of P. falciparum lactate dehydrogenase activity (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 2 % | Percent inhibition of P. falciparum Dd2 growth (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 10 % | Percent inhibition of HepG2 growth (at 10 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 94 % | Percent inhibition of P. falciparum 3D7 growth (at 2 uM) | GSK. | 20485427 |
XC50 (functional) | = 5.76 | XC50 determination of P. falciparum 3D7 growth | GSK. | 20485427 |
XC50 (functional) | = 1.72835 uM | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth. | ChEMBL. | 20485427 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.